Fatigue and low energy Some researchers report feeling tired during the first few weeks, particularly if caloric intake drops significantly
Although GLP-1RAs can play a favorable role in improving heart failure based on pre-clinical studies, whereas some clinical evidence relevantly have reported that GLP-1RAs treatment could be associated with adverse heart failure events, eg
Interested in optimizing your overall health
Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial
Asia Pacific is the fastest-growing region in the GLP-1 analogues market, propelled by the rising incidence of lifestyle-related disorders, expanding healthcare access, and a growing middle-class population seeking advanced therapies
Discussion of weight loss goals and expectations